Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.

Toragen is focused on uniquely selective drugs targeting cancers caused by the human papillomavirus (“HPV”)SAN DIEGO--(BUSINESS WIRE)--Toragen Inc., a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs targeting cancers caused by the human papillomav...

Related Keywords

San Diego , California , United States , Scripps Green Hospital , Texas , Torrey Pines , Andrew Sharabi , Daniel Foster , Sandra Coufal , University Of Notre Dame , Uc San Diego Health , Drug Administration , Toragen Inc , Head Of The Division Internal Medicine , Nasdaq , Management Board Of Tricida Inc , San Diego Based , Sibling Capital Ventures , Sibling Capital , Scientific Advisory Boards , Management Board , Biomedical Advisor , Genomics Institute , Novartis Research , Internal Medicine , Scripps Clinic , Texas Southwestern Medical School , Notre Dame , Assistant Professor , Radiation Medicine , Applied Sciences , Diego Health , Investigational New Drug , Neck Cancer , Cervical Cancer ,